266 related articles for article (PubMed ID: 26610333)
1. Effectiveness and safety of misoprostol distributed to antenatal women to prevent postpartum haemorrhage after child-births: a stepped-wedge cluster-randomized trial.
Ononge S; Campbell OM; Kaharuza F; Lewis JJ; Fielding K; Mirembe F
BMC Pregnancy Childbirth; 2015 Nov; 15():315. PubMed ID: 26610333
[TBL] [Abstract][Full Text] [Related]
2. The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial.
Weeks AD; Ditai J; Ononge S; Faragher B; Frye LJ; Durocher J; Mirembe FM; Byamugisha J; Winikoff B; Alfirevic Z
BMC Pregnancy Childbirth; 2015 Sep; 15():219. PubMed ID: 26370443
[TBL] [Abstract][Full Text] [Related]
3. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial.
Diop A; Daff B; Sow M; Blum J; Diagne M; Sloan NL; Winikoff B
Lancet Glob Health; 2016 Jan; 4(1):e37-44. PubMed ID: 26718808
[TBL] [Abstract][Full Text] [Related]
4. Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan.
Abbas DF; Mirzazada S; Durocher J; Pamiri S; Byrne ME; Winikoff B
Reprod Health; 2020 Jun; 17(1):88. PubMed ID: 32503556
[TBL] [Abstract][Full Text] [Related]
5. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.
Zuberi NF; Durocher J; Sikander R; Baber N; Blum J; Walraven G
BMC Pregnancy Childbirth; 2008 Aug; 8():40. PubMed ID: 18718007
[TBL] [Abstract][Full Text] [Related]
6. Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
Hashima-E-Nasreen ; Nahar S; Al Mamun M; Afsana K; Byass P
Glob Health Action; 2011; 4():. PubMed ID: 21845143
[TBL] [Abstract][Full Text] [Related]
7. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
[TBL] [Abstract][Full Text] [Related]
8. Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia.
Smith JM; Baawo SD; Subah M; Sirtor-Gbassie V; Howe CJ; Ishola G; Tehoungue BZ; Dwivedi V
BMC Pregnancy Childbirth; 2014 Jun; 14():189. PubMed ID: 24894566
[TBL] [Abstract][Full Text] [Related]
9. Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence.
Hundley VA; Avan BI; Sullivan CJ; Graham WJ
BJOG; 2013 Feb; 120(3):277-85; discussion 86-7. PubMed ID: 23190345
[TBL] [Abstract][Full Text] [Related]
10. Advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage.
Oladapo OT; Blum J; Abalos E; Okusanya BO
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009336. PubMed ID: 35819305
[TBL] [Abstract][Full Text] [Related]
11. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date.
Smith JM; Gubin R; Holston MM; Fullerton J; Prata N
BMC Pregnancy Childbirth; 2013 Feb; 13():44. PubMed ID: 23421792
[TBL] [Abstract][Full Text] [Related]
12. Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial.
Raghavan S; Geller S; Miller S; Goudar SS; Anger H; Yadavannavar MC; Dabash R; Bidri SR; Gudadinni MR; Udgiri R; Koch AR; Bellad MB; Winikoff B
BJOG; 2016 Jan; 123(1):120-7. PubMed ID: 26333044
[TBL] [Abstract][Full Text] [Related]
13. The Safety and Feasibility of a Family First Aid Approach for the Management of Postpartum Hemorrhage in Home Births: A Pre-post Intervention Study in Rural Pakistan.
Mary M; Jafarey S; Dabash R; Kamal I; Rabbani A; Abbas D; Durocher J; Tan YL; Winikoff B
Matern Child Health J; 2021 Jan; 25(1):118-126. PubMed ID: 33242210
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage.
Zgaya R; Ghadhab I; Triki MA; Briki R
Pan Afr Med J; 2020; 36():186. PubMed ID: 32952830
[TBL] [Abstract][Full Text] [Related]
15. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.
Derman RJ; Kodkany BS; Goudar SS; Geller SE; Naik VA; Bellad MB; Patted SS; Patel A; Edlavitch SA; Hartwell T; Chakraborty H; Moss N
Lancet; 2006 Oct; 368(9543):1248-53. PubMed ID: 17027730
[TBL] [Abstract][Full Text] [Related]
16. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana.
Geller S; Carnahan L; Akosah E; Asare G; Agyemang R; Dickson R; Kapungu C; Owusu-Ansah L; Robinson N; Mensah-Homiah J
BJOG; 2014 Feb; 121(3):319-25. PubMed ID: 24283350
[TBL] [Abstract][Full Text] [Related]
17. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial.
Mobeen N; Durocher J; Zuberi N; Jahan N; Blum J; Wasim S; Walraven G; Hatcher J
BJOG; 2011 Feb; 118(3):353-61. PubMed ID: 21176086
[TBL] [Abstract][Full Text] [Related]
18. Postpartum misoprostol for preventing maternal mortality and morbidity.
Hofmeyr GJ; Gülmezoglu AM; Novikova N; Lawrie TA
Cochrane Database Syst Rev; 2013 Jul; (7):CD008982. PubMed ID: 23857523
[TBL] [Abstract][Full Text] [Related]
19. A randomised placebo controlled trial of oral misoprostol in the third stage of labour.
Hofmeyr GJ; Nikodem VC; de Jager M; Gelbart BR
Br J Obstet Gynaecol; 1998 Sep; 105(9):971-5. PubMed ID: 9763047
[TBL] [Abstract][Full Text] [Related]
20. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG
PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
